Cell Therapy Raw Materials Market Report 2026

Cell Therapy Raw Materials Market Overview

• Cell Therapy Raw Materials market size has reached to $5.07 billion in 2025 • Expected to grow to $12.75 billion in 2030 at a compound annual growth rate (CAGR) of 20.2% • Growth Driver: Rising Adoption Of regenerative medicine Fuels Demand For The Market Due To Increasing Need For Advanced Therapies To Treat Chronic And Degenerative Diseases • Market Trend: Innovation And GMP Compliance Driving Advancements in Cell Therapy Raw Materials Manufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Therapy Raw Materials Market?

Cell therapy raw materials refer to the foundational substances and components used during the development, manufacturing, and processing of cell-based therapies. These materials are essential for maintaining the quality, consistency, and safety of cell cultures throughout various stages of therapy production. The main types of cell therapy raw materials are stem cell-based raw materials, gene therapy raw materials, and CAR-T cell therapy raw materials. Stem cell-based raw materials are specialized substances used to support the growth, maintenance, and differentiation of stem cells in cell therapy research and manufacturing. The product offerings include media, sera, cell culture supplements, antibodies, reagents and buffers, and others and are widely used by end users, including biopharmaceutical and pharmaceutical companies, contract research and manufacturing organizations, and others.

What Is The Cell Therapy Raw Materials Market Growth Forecast?

The cell therapy raw materials market size is expected to see exponential growth in the next few years. It will grow to $12.75 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to commercialization of cell and gene therapies, rising demand for car-t treatments, advancements in cell expansion and cryopreservation materials, increasing regulatory scrutiny on raw material quality, expansion of biopharmaceutical manufacturing capacity. Major trends in the forecast period include rising demand for high-quality and consistent cell culture media, increasing adoption of serum-free and chemically defined raw materials, growth in car-t and gene therapy manufacturing pipelines, expansion of outsourcing to specialized raw material suppliers, enhanced focus on regulatory compliance and traceability.

Global Cell Therapy Raw Materials Market Segmentation

1) By Therapy Area: Stem Cell Based Raw Materials, Gene Therapy Raw Materials, CAR-T Cell Therapy Raw Materials 2) By Product Type: Media, Sera, Cell Culture Supplements, Antibodies, Reagents And Buffers, Other Product Types 3) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organization And Contract Manufacturing Organization, Other End Users Subsegments: 1) By Stem Cell Based Raw Materials: Growth Factors, Cytokines, Cell Culture Media 2) By Gene Therapy Raw Materials: Transfection Reagents, Nucleotides And Enzymes, Cell Culture Media For Gene Modification 3) By Car-T Cell Therapy Raw Materials: T Cell Activation Reagents, Cell Expansion Media, Cryopreservation Agents

What Is The Driver Of The Cell Therapy Raw Materials Market?

The growing use of regenerative medicine is expected to propel the growth of the cell therapy raw materials market going forward. Regenerative medicine refers to the field of medicine that aims to restore or establish normal function by replacing, engineering, or regenerating human cells, tissues, or organs. Regenerative medicine is increasing due to the rising burden of chronic and degenerative diseases, as they drive demand for therapies that repair or replace damaged tissues rather than just managing symptoms. Cell therapy raw materials help advance regenerative medicine by providing the essential components, such as growth factors, cell culture media, enzymes, and scaffolds, needed to cultivate, expand, and maintain therapeutic cells that are used to repair or regenerate damaged tissues and organs. For instance, in January 2025, the National Library of Medicine, a US-based biomedical library, reported that 32 new gene therapies, including genetically modified cell therapies, had been approved in 2024. Therefore, the growing use of regenerative medicine is driving the growth of the cell therapy raw materials industry.

Key Players In The Global Cell Therapy Raw Materials Market

Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, ACROBiosystems Co Ltd., CellGenix GmbH, Promocell GmbH, RoosterBio Inc., Akron Biotech LLC.

Global Cell Therapy Raw Materials Market Trends and Insights

Major companies operating in the cell therapy raw materials market are focusing on developing innovative solutions, such as good manufacturing practice (GMP)-compliant manufacturing, to ensure product safety, consistency, and regulatory compliance throughout the cell therapy production process. Good manufacturing practice (GMP)-compliant manufacturing refers to a system that ensures products are consistently produced and controlled according to quality standards set by regulatory authorities to minimize risks involved in pharmaceutical and biotechnological production. For instance, in April 2025, Thermo Fisher Scientific Inc., a US-based American life science and clinical research company, launched a US advanced therapies collaboration center (ATxCC) to support the development and commercialization of cell and gene therapies. It accelerates cell therapy development by providing end-to-end cGMP manufacturing support, advanced technologies, and expert process optimization. It fosters collaboration to overcome manufacturing challenges and speed commercialization.

What Are Latest Mergers And Acquisitions In The Cell Therapy Raw Materials Market?

In January 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Akron Biotechnology to enhance cell therapy manufacturing by incorporating CGMP-compliant cytokines into Charles River’s Flex Platform, thereby streamlining processing, improving scalability, and ensuring regulatory compliance for advanced therapies. Akron Biotechnology is a US-based manufacturing company specializing in raw materials for cell and gene therapy development.

Regional Insights

North America was the largest region in the cell therapy raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Therapy Raw Materials Market?

The cell therapy raw materials market consists of sales of serum and serum-free supplements, cryopreservation systems, and buffer systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Therapy Raw Materials Market Report 2026?

The cell therapy raw materials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy raw materials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.